{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:33Z","timestamp":1793724273733,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03688-1","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:09:42Z","timestamp":1758805782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quadruple synergistic amplification of ferroptosis for precision glioblastoma therapy: a luteolin-coordinated ferric ion nanoplatform"],"prefix":"10.1186","volume":"23","author":[{"given":"Suyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-xu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-an","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"3688_CR1","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, et al. Natural coevolution of tumor and immunoenvironment in glioblastoma. Cancer Discov. 2022;12:2820\u201337.","journal-title":"Cancer Discov"},{"key":"3688_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255611","volume":"14","author":"F Yasinjan","year":"2023","unstructured":"Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, et al. Immunotherapy: a promising approach for glioma treatment. Front Immunol. 2023;14:1255611.","journal-title":"Front Immunol"},{"key":"3688_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842\u201350.","journal-title":"JAMA"},{"key":"3688_CR4","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, et al. Molecular mechanisms of ferroptosis and its role in cancer therapy. J Cell Mol Med. 2019;23:4900\u201312.","journal-title":"J Cell Mol Med"},{"key":"3688_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.974156","volume":"9","author":"S Zhuo","year":"2022","unstructured":"Zhuo S, He G, Chen T, Li X, Liang Y, Wu W, et al. Emerging role of ferroptosis in glioblastoma: therapeutic opportunities and challenges. Front Mol Biosci. 2022;9:974156.","journal-title":"Front Mol Biosci"},{"key":"3688_CR6","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.7150\/ijbs.96476","volume":"20","author":"Y Wei","year":"2024","unstructured":"Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H, et al. Targeting ferroptosis opens new avenues in gliomas. Int J Biol Sci. 2024;20:4674\u201390.","journal-title":"Int J Biol Sci"},{"key":"3688_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12964-023-01108-1","volume":"21","author":"S Wan","year":"2023","unstructured":"Wan S, Zhang G, Liu R, Abbas MN, Cui H. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment. Cell Commun Signal. 2023;21:115.","journal-title":"Cell Commun Signal"},{"key":"3688_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010449","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2023;24:449. https:\/\/doi.org\/10.3390\/ijms24010449","journal-title":"Int J Mol Sci"},{"key":"3688_CR9","volume":"18","author":"H Wang","year":"2023","unstructured":"Wang H, Qiao C, Guan Q, Wei M, Li Z. Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: novel insights and perspectives. Asian J Pharm Sci. 2023;18:100829.","journal-title":"Asian J Pharm Sci"},{"key":"3688_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jconrel.2024.01.004","volume":"368","author":"K Xue","year":"2024","unstructured":"Xue K, Yang R, An Y, Ding Y, Li S, Miao F, Liu D, Chen D, Tang Q. NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment. J Control Release. 2024;368:595\u2013606.","journal-title":"J Control Release"},{"key":"3688_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1515\/mr-2023-0029","volume":"3","author":"QTH Shubhra","year":"2023","unstructured":"Shubhra QTH. Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy. Med Rev. 2023;3:444\u20137.","journal-title":"Med Rev"},{"key":"3688_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12951-022-01385-x","volume":"20","author":"M Chen","year":"2022","unstructured":"Chen M, Li J, Shu G, Shen L, Qiao E, Zhang N, Fang S, Chen X, Zhao Z, Tu J, et al. Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization. J Nanobiotechnol. 2022;20:179.","journal-title":"J Nanobiotechnol"},{"key":"3688_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2023.09.024","volume":"363","author":"Q Ding","year":"2023","unstructured":"Ding Q, Tang W, Li X, Ding Y, Chen X, Cao W, et al. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer. J Control Release. 2023;363:221\u201334.","journal-title":"J Control Release"},{"key":"3688_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jbm.b.35139","volume":"111","author":"T Yang","year":"2023","unstructured":"Yang T, Hao S, Wang P, Qin Y, You G, Shi Y, Yang B, Zhang A, Guo L, Jiang T. Material properties of degradable alloy Fe-30Mn-0.6\u00a0N and its effect on ferroptosis in synoviocytes. J Biomed Mater Res B Appl Biomater. 2023;111:127\u201339.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"3688_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12951-024-02550-0","volume":"22","author":"Y Gong","year":"2024","unstructured":"Gong Y, Hu X, Chen M, Wang J. Recent progress of iron-based nanomaterials in gene delivery and tumor gene therapy. J Nanobiotechnol. 2024;22:309.","journal-title":"J Nanobiotechnol"},{"key":"3688_CR16","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1021\/acsami.1c22861","volume":"14","author":"W Tao","year":"2022","unstructured":"Tao W, Wang N, Ruan J, Cheng X, Fan L, Zhang P, et al. Enhanced ROS-boosted phototherapy against pancreatic cancer via Nrf2-mediated stress-defense pathway suppression and ferroptosis induction. ACS Appl Mater Interfaces. 2022;14:6404\u201316.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3688_CR17","doi-asserted-by":"publisher","first-page":"e2206053","DOI":"10.1002\/smll.202206053","volume":"19","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhang F, Chen K, Sun Z, Wang Z, Xue Y, Li M, Fan Q, Shen Q, Zhao Q. An activatable phototheranostic nanoplatform for tumor specific NIR-II fluorescence imaging and synergistic NIR-II Photothermal-Chemodynamic therapy. Small. 2023;19:e2206053.","journal-title":"Small"},{"key":"3688_CR18","first-page":"588","volume":"49","author":"R Saito","year":"2021","unstructured":"Saito R. [Chemotherapy for glioma]. No Shinkei Geka. 2021;49:588\u201396.","journal-title":"No Shinkei Geka"},{"key":"3688_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114853","volume":"197","author":"S Padmakumar","year":"2023","unstructured":"Padmakumar S, Amiji MM. Long-acting therapeutic delivery systems for the treatment of gliomas. Adv Drug Deliv Rev. 2023;197:114853.","journal-title":"Adv Drug Deliv Rev"},{"key":"3688_CR20","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang W, Fan W, Lau J, Deng L, Shen Z, Chen X. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48:2967\u20133014.","journal-title":"Chem Soc Rev"},{"key":"3688_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","volume":"369","author":"R Mu","year":"2024","unstructured":"Mu R, Sun H, Zeng Y, Tong Y, Tang P, Zhao M, et al. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy. J Control Release. 2024;369:458\u201374.","journal-title":"J Control Release"},{"key":"3688_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071393","author":"VE Silant\u2019ev","year":"2024","unstructured":"Silant\u2019ev VE, Belousov AS, Trukhin FO, Struppul NE, Shmelev ME, Patlay AA, et al. Rational design of pectin-chitosan polyelectrolyte nanoparticles for enhanced temozolomide delivery in brain tumor therapy. Biomedicines. 2024;12:1393. https:\/\/doi.org\/10.3390\/biomedicines12071393","journal-title":"Biomedicines"},{"key":"3688_CR23","doi-asserted-by":"publisher","first-page":"14469","DOI":"10.1021\/acsnano.4c01253","volume":"18","author":"Q Fan","year":"2024","unstructured":"Fan Q, Kuang L, Wang B, Yin Y, Dong Z, Tian N, et al. Multiple synergistic effects of the microglia membrane-bionic nanoplatform on mediate tumor microenvironment remodeling to amplify glioblastoma immunotherapy. ACS Nano. 2024;18:14469\u201386.","journal-title":"ACS Nano"},{"key":"3688_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jconrel.2020.12.036","volume":"330","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Liang J, Gao C, Wang A, Xia J, Hong C, et al. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. J Control Release. 2021;330:641\u201357.","journal-title":"J Control Release"},{"key":"3688_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10315","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang S, Hong X, Zhao M, Liu N, Liu H, Zhao J, et al. Nanocomposite hydrogels for biomedical applications. Bioeng Transl Med. 2022;7:e10315.","journal-title":"Bioeng Transl Med"},{"key":"3688_CR26","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.2147\/IJN.S208332","volume":"14","author":"H Yavarpour-Bali","year":"2019","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomed. 2019;14:4449\u201360.","journal-title":"Int J Nanomed"},{"key":"3688_CR27","doi-asserted-by":"crossref","unstructured":"Deepika; Maurya PK. Health Benefits of Quercetin in Age-Related Diseases. Molecules. 2022, 27.","DOI":"10.3390\/molecules27082498"},{"key":"3688_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijpharm.2013.08.017","volume":"456","author":"ZZ Chen","year":"2013","unstructured":"Chen ZZ, Lu Y, Du SY, Shang KX, Cai CB. Influence of borneol and muscone on geniposide transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model. Int J Pharm. 2013;456:73\u20139.","journal-title":"Int J Pharm"},{"key":"3688_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10393","volume":"8","author":"N Qi","year":"2023","unstructured":"Qi N, Duan W, Gao D, Ma N, Zhang J, Feng J, et al. Guide of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes. Bioeng Transl Med. 2023;8:e10393.","journal-title":"Bioeng Transl Med"},{"key":"3688_CR30","doi-asserted-by":"crossref","unstructured":"Wang M, Yi H, Zhan Z, Feng Z, Yang GG, Zheng Y, Zhang. D.-Y.J.A. A self-assembled nanomedicine for glucose supply interruption\u2010amplified low\u2010temperature photothermal therapy and anti\u2010prometastatic inflammatory processes of triple\u2010negative breast cancer. Aggregate. 2024;5:e622.","DOI":"10.1002\/agt2.622"},{"key":"3688_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122396","volume":"304","author":"W Nie","year":"2024","unstructured":"Nie W, Jiang A, Ou X, Zhou J, Li Z, Liang C, et al. Metal-polyphenol prison attenuated bacterial outer membrane vesicle for chemodynamics promoted in situ tumor vaccines. Biomaterials. 2024;304:122396.","journal-title":"Biomaterials"},{"key":"3688_CR32","doi-asserted-by":"publisher","first-page":"e23619","DOI":"10.1002\/jbt.23619","volume":"38","author":"A Goyal","year":"2024","unstructured":"Goyal A, Solanki K, Verma A, Luteolin. Nature\u2019s promising warrior against alzheimer\u2019s and parkinson\u2019s disease. J Biochem Mol Toxicol. 2024;38:e23619.","journal-title":"J Biochem Mol Toxicol"},{"key":"3688_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/ijms15010895","volume":"15","author":"D Sawmiller","year":"2014","unstructured":"Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, et al. Luteolin reduces Alzheimer\u2019s disease pathologies induced by traumatic brain injury. Int J Mol Sci. 2014;15:895\u2013904.","journal-title":"Int J Mol Sci"},{"key":"3688_CR34","doi-asserted-by":"crossref","unstructured":"Han S, Lin F, Qi Y, Liu C, Zhou L, Xia Y, Chen K, Xing J, Liu Z, Yu W et al. HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. Oxid Med Cell Longev. 2022, 2022, 3846217.","DOI":"10.1155\/2022\/3846217"},{"key":"3688_CR35","doi-asserted-by":"publisher","first-page":"124805","DOI":"10.1016\/j.colsurfa.2020.124805","volume":"598","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhao L, Shen G, Chang R, Yan XJC, Physicochemical SA, Aspects E. Coordination self-assembly of natural flavonoids into robust nanoparticles for enhanced in vitro chemo and photothermal cancer therapy. Colloid Surf A. 2020;598:124805.","journal-title":"Colloid Surf A"},{"key":"3688_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.neurol.2023.03.013","volume":"179","author":"MH Ahmed","year":"2023","unstructured":"Ahmed MH, Canney M, Carpentier A, Idbaih A. Overcoming the blood brain barrier in glioblastoma: status and future perspective. Rev Neurol (Paris). 2023;179:430\u20136.","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"3688_CR37","volume":"71","author":"V Rani","year":"2023","unstructured":"Rani V, Prabhu A. In vitro blood brain barrier models: molecular aspects and therapeutic strategies in glioma management. Curr Res Transl Med. 2023;71(1):103376.","journal-title":"Curr Res Transl Med"},{"key":"3688_CR38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.tibtech.2019.04.006","volume":"37","author":"A Oddo","year":"2019","unstructured":"Oddo A, Peng B, Tong Z, Wei Y, Tong WY, Thissen H, et al. Advances in microfluidic blood-brain barrier (BBB) models. Trends Biotechnol. 2019;37:1295\u2013314.","journal-title":"Trends Biotechnol"},{"key":"3688_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","volume":"8","author":"D Gong","year":"2022","unstructured":"Gong D, Chen M, Wang Y, Shi J, Hou Y. Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov. 2022;8:427.","journal-title":"Cell Death Discov"},{"key":"3688_CR40","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1039\/D3TB00029J","volume":"11","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zheng J, Du M, Yang Y, Li X, Chen H, et al. An iron-containing ferritin-based nanosensitizer for synergistic ferroptosis\/sono-photodynamic cancer therapy. J Mater Chem B. 2023;11:4958\u201371.","journal-title":"J Mater Chem B"},{"key":"3688_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:09:47Z","timestamp":1758805787000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3688"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03688-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animals in this study are handled according to the protocol approved by the Institutional Animal Use and Care Committee of Shenzhen Institute for Drug Control (SZIDC-YL-20240331).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the journal policies and submit this manuscript in accordance with those policies. All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"605"}}